Evogene Ltd.

1.26
0.01 (0.80%)
At close: Apr 01, 2025, 3:59 PM
1.21
-3.97%
After-hours: Apr 01, 2025, 07:11 PM EDT

Evogene Ltd. Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue 5.64M 1.68M 930K 1.04M 753K
Cost of Revenue 4.24M 909K 767K 574K 334K
Gross Profit 1.4M 766K 163K 466K 419K
Operating Income -26.39M -26.94M -30.95M -24.81M -21.17M
Interest Income 1.25M 516K 1.94M 1.59M 2.46M
Pretax Income -25.99M -29.75M -30.43M -26.17M -19.09M
Net Income -23.88M -26.64M -27.79M -23.37M -18.11M
Selling & General & Admin 9.68M 10.41M 7.25M 5.32M 3.77M
Research & Development 18.11M 20.79M 23.86M 19.96M 17.82M
Other Expenses n/a -3.5M n/a 15.02M -41K
Operating Expenses 27.79M 27.71M 31.12M 25.28M 21.59M
Interest Expense 171K 3.33M 1.41M 2.95M 386K
Selling & Marketing Expenses 1.01M 3.93M 653K 520K n/a
Cost & Expenses 32.03M 28.62M 31.88M 25.85M 21.92M
Income Tax -33K 90K 13K 32K 24K
Shares Outstanding (Basic) 4.57M 4.12M 4.04M 2.82M 25.75M
Shares Outstanding (Diluted) 4.57M 4.12M 4.04M 2.82M 25.75M
EPS (Basic) -5.23 -6.46 -6.87 -8.3 -0.7
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA -23.2M -26.93M -27.8M -23.18M -15.97M
Depreciation & Amortization 2.61M 2.58M 2.23M 2.73M 2.77M